SWIPE

1/6

ReThink Possible

2/6

PLEASE REVIEW THE IMPORTANT SAFETY INFORMATION FOR NUULIFE®

Review ISI
Review ISI

PLEASE REVIEW THE IMPORTANT SAFETY INFORMATION FOR NUULIFE®

Indications and Usage

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Integer malesuada. Nullam sapien sem, ornare ac, nonummy non, lobortis a enim. Vestibulum erat nulla, ullamcorper nec, rutrum non, nonummy ac, erat. Sed vel lectus. Donec odio tempus molestie, porttitor ut, iaculis quis, sem. Etiam dui sem, fermentum vitae, sagittis id, malesuada in, quam. Duis sapien nunc, commodo et, interdum suscipit, sollicitudin et, dolor. Nulla accumsan, elit sit amet varius semper, nulla mauris mollis quam, tempor suscipit diam nulla vel leo. Itaque earum rerum hic tenetur a sapiente delectus, ut aut reiciendis voluptatibus maiores alias consequatur aut perferendis doloribus asperiores repellat.

Important Safety Information

Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Nam quis nulla. Duis pulvinar. In laoreet, magna id viverra tincidunt, sem odio bibendum justo, vel imperdiet sapien wisi sed libero. Vivamus porttitor turpis ac leo. Morbi leo mi, nonummy eget tristique non, rhoncus non leo. Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Suspendisse sagittis ultrices augue. Nullam sit amet magna in magna gravida vehicula. Duis viverra diam non justo. Integer imperdiet lectus quis justo.

  • Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Integer malesuada.
  • Vestibulum erat nulla, ullamcorper nec, rutrum non, nonummy ac, erat. Sed vel lectus. Donec odio tempus molestie, porttitor ut, iaculis quis, sem.
  • Etiam dui sem, fermentum vitae, sagittis id, malesuada in, quam.
  • Itaque earum rerum hic tenetur a sapiente delectus, ut aut reiciendis voluptatibus maiores alias consequatur aut perferendis doloribus asperiores repellat.

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Integer malesuada. Nullam sapien sem, ornare ac, nonummy non, lobortis a enim. Vestibulum erat nulla, ullamcorper nec, rutrum non, nonummy ac, erat. Sed vel lectus. Donec odio tempus molestie, porttitor ut, iaculis quis, sem.

In laoreet, magna id viverra tincidunt, sem odio bibendum justo, vel imperdiet sapien wisi sed libero. Vivamus porttitor turpis ac leo. Morbi leo mi, nonummy eget tristique non, rhoncus non leo. Lorem ipsum dolor sit amet, consectetuer adipiscing elit.

Lorem ipsum dolor sit amet

Duis sapien nunc, commodo et, interdum suscipit, sollicitudin et, dolor. Nulla accumsan, elit sit amet varius semper, nulla mauris mollis quam, tempor suscipit diam nulla vel leo. Itaque earum rerum hic tenetur a sapiente delectus, ut aut reiciendis voluptatibus maiores alias consequatur aut perferendis doloribus asperiores repellat.

I have read the ISI

3/6

During 2013–2016, 8.1% of American adults aged 20 and over had depression in a given 2-week period.1

4/6

Studies show patients taking NUULIFE® report better outcomes, 70% of the time after a single dose

  • NUULIFE 50 mg delivered significant improvement in HAM-D17 total score vs placebo at week 8 (P<0.001)
  • In the 6-month, double-blind phase of trial #2, NUULIFE 50 mg reduced the probability of relapse by more than half

5/6

On average what percentage of patients that you treat suffer from major depression?

Less than 10%
Between 11% and 25%
Approximately 50%
>50%

6/6

NUULIFE® can help your patients rethink possible

  • Patients taking NUULIFE 50 mg showed improved functional outcomes as measured by the Sheehan Disability Scale
  • NNULIFE 50 mg showed a 41% improvement vs 22% on placebo
  • NUULIFE 50 mg reduced the probability of relapse by more than half